Intravitreal Triamcinolone Acetonide for Diffuse Diabetic Macular Edema: Phase 2 Trial Comparing 4 mg vs 2 mg

American Journal of Ophthalmology

Volumn 142, Issue 5, 2006, Pages

  Audren, François ^a   Lecleire Collet, Amélie ^a   Erginay, Ali ^a   Haouchine, Belkacem ^a   Benosman, Rym ^a   Bergmann, Jean François ^a   Gaudric, Alain ^a   Massin, Pascale ^a  

^a HÔPITAL LARIBOISIÈRE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

TRIAMCINOLONE ACETONIDE;

ADULT; AGED; ARTICLE; CATARACT; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETIC MACULAR EDEMA; DISEASE COURSE; DRUG EFFICACY; DRUG SAFETY; HUMAN; INTRAOCULAR PRESSURE; INTRAOCULAR PRESSURE ABNORMALITY; LASER COAGULATION; OPTICAL COHERENCE TOMOGRAPHY; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STATISTICAL SIGNIFICANCE; TREATMENT OUTCOME; VISUAL ACUITY;

EID: 33750051350     PISSN: 00029394     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajo.2006.06.011     Document Type: Article

References (17)

1. Klein R., Klein B.E., and Moss S.E. Visual impairment in diabetes. Ophthalmology 91 (1984) 1-9
2. Jonas J.B., Kreissig I., Sofker A., and Degenring R.F. Intravitreal injection of triamcinolone for diffuse diabetic macular edema. Arch Ophthalmol 121 (2003) 57-61
3. Jonas J.B., Degenring R.F., Kamppeter B.A., Kreissig I., and Akkoyun I. Duration of the effect of intravitreal triamcinolone acetonide as treatment for diffuse diabetic macular edema. Am J Ophthalmol 138 (2004) 158-160
4. Jonas J.B., Harder B., and Kamppeter B.A. Inter-eye difference in diabetic macular edema after unilateral intravitreal injection of triamcinolone acetonide. Am J Ophthalmol 138 (2004) 970-977
5. Martidis A., Duker J.S., Greenberg P.B., et al. Intravitreal triamcinolone for refractory diabetic macular edema. Ophthalmology 109 (2002) 920-927
6. Massin P., Audren F., Haouchine B., et al. Intravitreal triamcinolone acetonide for diabetic diffuse macular edema: preliminary results of a prospective controlled trial. Ophthalmology 111 (2004) 218-224 discussion 224-225
7. Sutter F.K., Simpson J.M., and Gillies M.C. Intravitreal triamcinolone for diabetic macular edema that persists after laser treatment: three-month efficacy and safety results of a prospective, randomized, double-masked, placebo-controlled clinical trial. Ophthalmology 111 (2004) 2044-2049
8. Spandau U.H., Derse M., Schmitz-Valckenberg P., Papoulis C., and Jonas J.B. Dosage dependency of intravitreal triamcinolone acetonide as treatment for diabetic macular oedema. Br J Ophthalmol 89 (2005) 999-1003
9. Chylack Jr. L.T., Wolfe J.K., Singer D.M., et al. The Lens Opacities Classification System III. The Longitudinal Study of Cataract Study Group. Arch Ophthalmol 111 (1993) 831-836
10. Massin P., Vicaut E., Haouchine B., Erginay A., Paques M., and Gaudric A. Reproducibility of retinal mapping using optical coherence tomography. Arch Ophthalmol 119 (2001) 1135-1142
11. Massin P., Erginay A., Haouchine B., Mehidi A.B., Paques M., and Gaudric A. Retinal thickness in healthy and diabetic subjects measured using optical coherence tomography mapping software. Eur J Ophthalmol 12 (2002) 102-108
12. Chan A., and Duker J.S. A standardized method for reporting changes in macular thickening using optical coherence tomography. Arch Ophthalmol 123 (2005) 939-943
13. Audren F., Tod M., Massin P., et al. Pharmacokinetic-pharmacodynamic modeling of the effect of triamcinolone acetonide on central macular thickness in patients with diabetic macular edema. Invest Ophthalmol Vis Sci 45 (2004) 3435-3441
14. Beer P.M., Bakri S.J., Singh R.J., Liu W., Peters III G.B., and Miller M. Intraocular concentration and pharmacokinetics of triamcinolone acetonide after a single intravitreal injection. Ophthalmology 110 (2003) 681-686
15. Jonas J.B., Degenring R.F., Kreissig I., Akkoyun I., and Kamppeter B.A. Intraocular pressure elevation after intravitreal triamcinolone acetonide injection. Ophthalmology 112 (2005) 593-598
16. Smithen L.M., Ober M.D., Maranan L., and Spaide R.F. Intravitreal triamcinolone acetonide and intraocular pressure. Am J Ophthalmol 138 (2004) 740-743
17. Garcia-Arumi J., Boixadera A., Giralt J., et al. Comparison of different techniques for purification of triamcinolone acetonide suspension for intravitreal use. Br J Ophthalmol 89 (2005) 1112-1114